Renin-angiotensin blockade and kidney disease
- 22 August 2008
- journal article
- editorial
- Published by Elsevier BV in The Lancet
- Vol. 372 (9638), 511-512
- https://doi.org/10.1016/s0140-6736(08)61212-x
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trialThe Lancet, 2008
- Meta-analysis: Effect of Monotherapy and Combination Therapy with Inhibitors of the Renin–Angiotensin System on Proteinuria in Renal DiseaseAnnals of Internal Medicine, 2008
- Antihypertensive Therapy in the Presence of ProteinuriaAmerican Journal of Kidney Diseases, 2007
- Controversy about COOPERATE ABPM Trial DataAmerican Journal of Nephrology, 2006
- Effect of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes: systematic review and meta-analysisThe Lancet, 2005
- MastheadAmerican Journal of Kidney Diseases, 2004
- Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood PressureHypertension, 2003
- Long-term effects of antihypertensive regimens on renal hemodynamics and proteinuriaKidney International, 1993
- Longitudinal Studies on the Rate of Decline in Renal Function with AgeJournal of the American Geriatrics Society, 1985
- The Effect of Age on Creatinine Clearance in Men: A Cross-sectional and Longitudinal StudyJournal of Gerontology, 1976